SAMe and renal insufficiency —
A National Institutes of Health study to assess the effects of the over-the-counter antidepressant SAMe on homocysteine and related metabolic factors.
Primary investigators: Teodoro Bottiglieri, PhD, Andrew Fenves, MD, Cara East, MD
Please click the "Continue Session" button below to continue using the website. To end your session please click the "End Session" button below. After 5 minutes of inactivity your session will be terminated and you will be required to log in again.